2013      2012     2011     2010     2009     2008     2007     2006     2005     2004     2003     journal covers          PubMed Search  

1. Bryan, R. A., O. Zaragoza, T. Zhang, G. Ortiz, A. Casadevall, and E. Dadachova. 2005. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell 4:465-75.  

2. Cappitelli, F., S. Vicini, P. Piaggio, P. Abbruscato, E. Princi, A. Casadevall, J. D. Nosanchuk, and E. Zanardini. 2005. Investigation of fungal deterioration of synthetic paint binders using vibrational spectroscopic techniques. Macromol Biosci 5:49-57.

3. Casadevall, A. 2005. Host as the variable: model hosts approach the immunological asymptote. Infect Immun 73:3829-32.  

4. Casadevall, A. 2005. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Fungal Genet Biol 42:98-106.  

5. Casadevall, A., and L. Pirofski. 2005. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr Mol Med 5:421-33.

6. Casadevall, A., and L. A. Pirofski. 2005. Feasibility and prospects for a vaccine to prevent cryptococcosis. Med Mycol 43:667-80.

7. Casadevall, A., and L. A. Pirofski. 2005. The potential of antibody-mediated immunity in the defence against biological weapons. Expert Opin Biol Ther 5:1359-72.

8. Dadachova, E., and A. Casadevall. 2005. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases. Expert Opin Drug Deliv 2:1075-84.

9. Eisenman, H. C., J. D. Nosanchuk, J. B. Webber, R. J. Emerson, T. A. Camesano, and A. Casadevall. 2005. Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry 44:3683-93.  

10. Fries, B. C., E. Cook, X. Wang, and A. Casadevall. 2005. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans. Antimicrob Agents Chemother 49:350-7.  

11. Fries, B. C., S. C. Lee, R. Kennan, W. Zhao, A. Casadevall, and D. L. Goldman. 2005. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 73:1779-87.  

12. Garcia-Rivera, J., H. C. Eisenman, J. D. Nosanchuk, P. Aisen, O. Zaragoza, T. Moadel, E. Dadachova, and A. Casadevall. 2005. Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates. Fungal Genet Biol 42:989-98.  

13. Garcia-Rivera, J., S. C. Tucker, M. Feldmesser, P. R. Williamson, and A. Casadevall. 2005. Laccase expression in murine pulmonary Cryptococcus neoformans infection. Infect Immun 73:3124-7.  

14. Jain, N., B. L. Wickes, S. M. Keller, J. Fu, A. Casadevall, P. Jain, M. A. Ragan, U. Banerjee, and B. C. Fries. 2005. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J Clin Microbiol 43:5733-42.  

15. Larsen, R. A., P. G. Pappas, J. Perfect, J. A. Aberg, A. Casadevall, G. A. Cloud, R. James, S. Filler, and W. E. Dismukes. 2005. Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49:952-8.  

16. Luo, Y., S. C. Tucker, and A. Casadevall. 2005. Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G₁ to S¹. J Immunol 174:7226-33.  

17. Mandal, P., U. Banerjee, A. Casadevall, and J. D. Nosanchuk. 2005. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J Clin Microbiol 43:4766-72.  

18. Martinez, L. R., and A. Casadevall. 2005. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73:6350-62.  

19. McClelland, E. E., W. T. Perrine, W. K. Potts, and A. Casadevall. 2005. Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines. Infect Immun 73:7047-50.  

20. McClelland, E. E. B., P. Casadevall, A. 2005. Coping with Multiple Virulence Factors. Which Is Most Important? Plos Pathology 1:287-288.  

21. McLean, G. R., M. Torres, B. Trotter, M. Noseda, S. Bryson, E. F. Pai, J. W. Schrader, and A. Casadevall. 2005. A point mutation in the C_H3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity. Mol Immunol 42:1111-9.  

22. Mednick, A. J., J. D. Nosanchuk, and A. Casadevall. 2005. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 73:2012-9.  

23. Monari, C., F. Bistoni, A. Casadevall, E. Pericolini, D. Pietrella, T. R. Kozel, and A. Vecchiarelli. 2005. Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. J Infect Dis 191:127-37.  

24. Monari, C., E. Pericolini, G. Bistoni, A. Casadevall, T. R. Kozel, and A. Vecchiarelli. 2005. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. J Immunol 174:3461-8.  

25. Morris-Jones, R., B. L. Gomez, S. Diez, M. Uran, S. D. Morris-Jones, A. Casadevall, J. D. Nosanchuk, and A. J. Hamilton. 2005. Synthesis of melanin pigment by Candida albicans in vitro and during infection. Infect Immun 73:6147-50.  

26. Nielsen, K., G. M. Cox, A. P. Litvintseva, E. Mylonakis, S. D. Malliaris, D. K. Benjamin, Jr., S. S. Giles, T. G. Mitchell, A. Casadevall, J. R. Perfect, and J. Heitman. 2005. Cryptococcus neoformans α strains preferentially disseminate to the central nervous system during coinfection. Infect Immun 73:4922-33.  

27. Oscarson, S., M. Alpe, P. Svahnberg, A. Nakouzi, and A. Casadevall. 2005. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. Vaccine 23:3961-72.  

28. Rivera, J., and A. Casadevall. 2005. Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against cryptococcus neoformans. J Immunol 174:8017-26.  

29. Rivera, J., O. Zaragoza, and A. Casadevall. 2005. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect Immun 73:1141-50.  

30. Shao, X., A. Mednick, M. Alvarez, N. van Rooijen, A. Casadevall, and D. L. Goldman. 2005. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 175:3244-51.  

31. Shao, X., J. Rivera, R. Niang, A. Casadevall, and D. L. Goldman. 2005. A dual role for TGF-β1 in the control and persistence of fungal pneumonia. J Immunol 175:6757-63.  

32. Torres, M., R. May, M. D. Scharff, and A. Casadevall. 2005. Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype. J Immunol 174:2132-42.  

33. Zaragoza, O., C. Mihu, A. Casadevall, and J. D. Nosanchuk. 2005. Effect of Amphotericin B on Capsule and Cell Size in Cryptococcus neoformans during Murine Infection. Antimicrob Agents Chemother 49:4358-61.